Different Surgical Modalities in the Management of Pelvi-ureteric Junction Obstruction
Not Applicable
Active, not recruiting
- Conditions
- Pelvi-ureteric Junction Obstruction
- Registration Number
- NCT06822270
- Lead Sponsor
- Assiut University
- Brief Summary
The study compared open pyeloplasty (OP) and laparoscopic pyeloplasty (LP) for treating Pelvi-ureteric Junction Obstruction (PUJO) in 40 patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Age between 7 months and 60 years. Diagnosed with Pelvi-ureteric Junction Obstruction (PUJO). Glomerular Filtration Rate (GFR) greater than 10 ml/min. Open to both genders.
Exclusion Criteria
- Active infection. GFR less than 10 ml/min. Presence of a single kidney. Patients with kidney or multiple congenital anomalies. Pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Operative Success Rate 3 days evaluating the effectiveness of each surgical method in resolving PUJO
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers predict surgical success in open vs laparoscopic pyeloplasty for PUJO?
How does laparoscopic pyeloplasty compare to open surgery in postoperative complication rates for PUJO?
Are molecular markers like urodynamic profiles linked to long-term outcomes in PUJO surgical treatments?
What adverse event profiles differentiate open and laparoscopic pyeloplasty in managing PUJO?
How effective is robotic-assisted pyeloplasty compared to traditional methods for Pelvi-ureteric Junction Obstruction?
Trial Locations
- Locations (1)
Faculty of Medicine Al-Azhar University
🇪🇬Assuit, Egypt